II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease

The II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease will take place on July 31st, 2019 at the Syrian-Lebanese Hospital in São Paulo.

Se acerca el IV Simposio de Cardiopatía Isquémica del ICBA

This event seeks to provide a better understanding of indications and clinical and interventional strategies for complex heart conditions, such as left main coronary artery obstructions, patients with acute coronary syndromes, patients at high risk for bleeding and an indication for coronary intervention, as well as percutaneous approaches to aortic stenosis (TAVR), mitral regurgitation, left atrial appendage closure, foramen ovale closure, etc.

Topics will be addressed dynamically and interactively, with clinical case presentations, conferences, and discussions, so as to provide information and improve the integration of new technologies into clinical practice.

Furthermore, this event will feature first-class international faculties.

Special Benefits

50% Off in Registration Fees for SOLACI Members!

SOLACI members registering for this event enjoy a 50% discount in the registration fee. Select “SOLACI member” in the registry system for this event and follow the instructions.

Those attending the SOLACI-SBHCI 2019 Congress will have a 50% discount on registrations to the II International Symposium of Innovations in the Treatment of Coronary and Structural Diseases

More information and registration HERE (this website is in portuguese language)

If you have questions or queries, write to secretaria.iep@hsl.org.br

This symposium is destined to: healthcare professionals, cardiologists and interventional cardiologists, cardiovascular surgeons, students, residents, nurses, and multidisciplinary teams seeking to stay updated on the latest transcatheter cardiology strategies.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....